P.PSH.1493 - DTS: Diathermic Syncope ®: revision of dossier for regulatory assessment in the EU
DTS: Diathermic Syncope ® technology (DTS) for stunning of cattle has been developed and provides consistent induction of insensibility at the time of slaughter.
| Project start date: | 10 January 2024 |
| Project end date: | 22 February 2025 |
| Publication date: | 02 October 2024 |
| Project status: | Completed |
| Livestock species: | Grain-fed Cattle, Grass-fed Cattle |
| Relevant regions: | Southern Australia, Northern Australia, National, NSW, Western Australia, Victoria, Cold wet, South Australia, Dry, Queensland, Mediterranean, Tropical warm season wet, Northern Territory, Sub-tropical moist, Tasmania, Sub-tropical sub-humid, Eastern Australia, Temperate, Temperate sub-humid, Tropical Moist, International, Tropical wet |
|
Download Report
(2.8 MB)
|
|
Summary
DTS: Diathermic Syncope ® technology (DTS) for stunning of cattle has been developed and provides consistent induction of insensibility at the time of slaughter. In order gain regulatory approval in Europe, an application needs to be made addressing the criteria important to this market. A previous submission raised questions and a request from the European Food Safety Authority (EFSA) Animal Health and Welfare (AHAW) Panel to re-analyse some electroencephalogram (EEG) data. The technical dossier has now been revised and resubmitted to the European Food Safety Authority, so consideration of the application may continue.
Objectives
1. Re-analysis of existing EEG data according to the requirements of the EFSA AHAW panel.
2. Revision of the dossier provided to EFSA according to the request of the EFSA AHAW panel.
3. Submit the revised dossier for EFSA AHAW consideration.
All three objectives have been achieved.
Key findings
The resubmitted technical dossier makes better use of the data collected to support the acceptance of the DTS method of stunning. The considerations of the Panel and the eventual outcome cannot be anticipated, but resubmission has increased the likelihood of a successful outcome. Alternatively, the Panel would be in a better position to specify the further evidence required before acceptance in Europe. This version of the technical dossier is the most complete and comprehensive exposition of DTS: Diathermic Syncope®.
Benefits to industry
Acceptance of DTS in Europe would allow the technology to be used in this market, and also meat processed from animals stunned using this technology could be sold in Europe. Europe is one of the few markets with prescriptive animal stunning requirements, so its acceptance of the technology would be influential in markets with less prescriptive requirements.
Future research
The dossier prepared for EFSA is valuable as a technical reference for applications in other markets. Regulatory acceptance is a prerequisite for acceptance by religious authorities.
More information
| Project manager: | Darryl Heidke |
| Contact email: | reports@mla.com.au |
| Primary researcher: | Wagstaff Food Services Pty Ltd |
